Overview A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis Status: Completed Trial end date: 2019-07-08 Target enrollment: Participant gender: Summary The aim of this study is to evaluate safety, tolerability, and efficacy of PRCL-02 in moderate to severe chronic plaque psoriasis Phase: Phase 2 Details Lead Sponsor: PRCL Research Inc.